A detailed history of Satovsky Asset Management LLC transactions in Alpha Tau Medical Ltd. stock. As of the latest transaction made, Satovsky Asset Management LLC holds 53,606 shares of DRTS stock, worth $122,221. This represents 0.03% of its overall portfolio holdings.

Number of Shares
53,606
Previous 53,606 -0.0%
Holding current value
$122,221
Previous $135,000 5.93%
% of portfolio
0.03%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$2.05 - $2.9 $10,274 - $14,534
5,012 Added 10.31%
53,606 $135,000
Q1 2024

Apr 23, 2024

SELL
$2.84 - $3.35 $27,934 - $32,950
-9,836 Reduced 16.83%
48,594 $143,000
Q4 2023

Jan 23, 2024

BUY
$2.75 - $3.89 $160,682 - $227,292
58,430 New
58,430 $175,000

Others Institutions Holding DRTS

About Alpha Tau Medical Ltd.


  • Ticker DRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,011,296
  • Market Cap $157M
  • Description
  • Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...
More about DRTS
Track This Portfolio

Track Satovsky Asset Management LLC Portfolio

Follow Satovsky Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Satovsky Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Satovsky Asset Management LLC with notifications on news.